PubRank

Mark W Tyndall

Author PubWeight™ 134.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ 2003 4.38
2 Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med 2007 4.14
3 Structural and environmental barriers to condom use negotiation with clients among female sex workers: implications for HIV-prevention strategies and policy. Am J Public Health 2009 3.85
4 Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ 2002 3.70
5 Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet Infect Dis 2004 3.20
6 Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ 2003 3.19
7 The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility. Int J Drug Policy 2008 3.05
8 Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS 2002 2.74
9 Displacement of Canada's largest public illicit drug market in response to a police crackdown. CMAJ 2004 2.63
10 Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ 2004 2.62
11 The impact of a police presence on access to needle exchange programs. J Acquir Immune Defic Syndr 2003 2.37
12 Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend 2006 2.33
13 Hepatitis C virus reinfection in injection drug users. Hepatology 2006 2.25
14 A review of barriers and facilitators of HIV treatment among injection drug users. AIDS 2008 2.21
15 Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ 2003 2.18
16 Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther 2004 2.14
17 Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. CMAJ 2003 2.08
18 Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ 2006 2.06
19 Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS 2010 2.04
20 Community-based HIV prevention research among substance-using women in survival sex work: the Maka Project Partnership. Harm Reduct J 2007 2.02
21 Attendance at supervised injecting facilities and use of detoxification services. N Engl J Med 2006 1.83
22 Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction 2007 1.81
23 Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J 2004 1.77
24 Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy. J Infect Dis 2003 1.77
25 Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia. AIDS 2006 1.72
26 Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia. Am J Public Health 2008 1.71
27 Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr 2002 1.69
28 Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health 2003 1.66
29 Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug Alcohol Depend 2007 1.64
30 Sexual and drug-related vulnerabilities for HIV infection among women engaged in survival sex work in Vancouver, Canada. Can J Public Health 2008 1.63
31 Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world. AIDS 2003 1.63
32 The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users. J Acquir Immune Defic Syndr 2003 1.54
33 Frequent needle exchange use and HIV incidence in Vancouver, Canada. Am J Med 2007 1.53
34 Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med 2005 1.52
35 Requiring help injecting independently predicts incident HIV infection among injection drug users. J Acquir Immune Defic Syndr 2005 1.48
36 Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol 2007 1.44
37 Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996. AIDS 2002 1.41
38 Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr 2002 1.38
39 Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. J Urban Health 2003 1.38
40 An external evaluation of a peer-run "unsanctioned" syringe exchange program. J Urban Health 2003 1.38
41 Occupational stigma as a primary barrier to health care for street-based sex workers in Canada. Cult Health Sex 2011 1.37
42 Access and utilization of HIV treatment and services among women sex workers in Vancouver's Downtown Eastside. J Urban Health 2005 1.35
43 Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users. Harm Reduct J 2006 1.33
44 Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility. Am J Public Health 2006 1.26
45 Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction 2004 1.26
46 Injection drug users' perceptions regarding use of a medically supervised safer injecting facility. Addict Behav 2006 1.26
47 Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting. BMC Public Health 2009 1.25
48 A dose-response relationship between exposure to a large-scale HIV preventive intervention and consistent condom use with different sexual partners of female sex workers in southern India. BMC Public Health 2011 1.25
49 Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Subst Abuse Treat Prev Policy 2006 1.25
50 Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STDS 2009 1.25
51 HIV/AIDS in Vancouver, British Columbia: a growing epidemic. Harm Reduct J 2009 1.24
52 Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users. J Infect 2005 1.21
53 Conducting HIV/AIDS research with indoor commercial sex workers: reaching a hidden population. Prog Community Health Partnersh 2007 1.21
54 Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health 2008 1.20
55 HIV and HCV prevalence and gender-specific risk profiles of crack cocaine smokers and dual users of injection drugs. Subst Use Misuse 2008 1.18
56 Determinants of cutaneous injection-related infection care at a supervised injecting facility. Ann Epidemiol 2009 1.14
57 Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users. Antivir Ther 2004 1.12
58 Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a canadian setting. Arch Pediatr Adolesc Med 2010 1.09
59 Management of HCV and HIV infections among people who inject drugs. Curr Opin HIV AIDS 2011 1.07
60 Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility. Am J Public Health 2007 1.06
61 A description of a peer-run supervised injection site for injection drug users. J Urban Health 2005 1.06
62 Nonadherence to antiretroviral therapy among a community with endemic rates of injection drug use. J Int Assoc Physicians AIDS Care (Chic) 2005 1.04
63 Individual and structural vulnerability among female youth who exchange sex for survival. J Adolesc Health 2011 1.04
64 A peer-led mobile outreach program and increased utilization of detoxification and residential drug treatment among female sex workers who use drugs in a Canadian setting. Drug Alcohol Depend 2010 1.04
65 Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility. Int J Drug Policy 2008 1.02
66 Potential uptake and correlates of willingness to use a supervised smoking facility for noninjection illicit drug use. J Urban Health 2005 1.01
67 Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents. Liver Int 2013 1.01
68 Factors associated with public injecting among users of Vancouver's supervised injection facility. Am J Drug Alcohol Abuse 2007 1.00
69 Validity of self-reported antiretroviral therapy use among injection drug users. J Acquir Immune Defic Syndr 2006 0.95
70 Clients of indoor commercial sex workers: heterogeneity in patronage patterns and implications for HIV and STI propagation through sexual networks. Sex Transm Dis 2007 0.95
71 Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health 2010 0.93
72 Validity of self-reported adherence among injection drug users. J Int Assoc Physicians AIDS Care (Chic) 2008 0.92
73 Rate of methadone use among Aboriginal opioid injection drug users. CMAJ 2007 0.90
74 The role of diet in predicting iron deficiency anemia in HIV-positive women. Can J Diet Pract Res 2012 0.89
75 Rationale to evaluate medically supervised safer smoking facilities for non-injection illicit drug users. Can J Public Health 2005 0.88
76 Patterns of opioid and cocaine co-use: a descriptive study in a Canadian sample of untreated opioid-dependent individuals. Exp Clin Psychopharmacol 2005 0.85
77 Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users. Addiction 2007 0.84
78 Preliminary development of a scale to measure stigma relating to sexually transmitted infections among women in a high risk neighbourhood. BMC Womens Health 2008 0.82
79 Health and social services accessed by a cohort of Canadian illicit opioid users outside of treatment. Can J Public Health 2006 0.81
80 "Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy. J Acquir Immune Defic Syndr 2002 0.81
81 Establishing a community-based participatory research partnership among people who use drugs in Ottawa: the PROUD cohort study. Harm Reduct J 2014 0.81
82 Factors associated with numbers of client partners of female sex workers across five districts in South India. Sex Transm Dis 2010 0.80
83 The prevalence and incidence of sexually transmitted infections in a prospective cohort of injection drug users in Vancouver, British Columbia. Can J Infect Dis Med Microbiol 2005 0.80
84 Demographics, sexual risk behaviours and uptake of screening for sexually transmitted infections among attendees of a weekly women-only community clinic program. Can J Public Health 2008 0.79
85 Regional patterns of risk for sexually transmitted infections in British Columbia. Health Rep 2010 0.78
86 Contribution of HIV to mortality among injection drug users in the era of HAART. J Acquir Immune Defic Syndr 2007 0.77
87 Factors associated with buying and selling syringes among injection drug users in a setting of one of North America's largest syringe exchange programs. Subst Use Misuse 2006 0.77
88 Individual and jurisdictional factors associated with voluntary HIV testing in Canada: Results of a national survey, 2011. Can J Public Health 2014 0.77
89 Challenges in initiating antiretroviral therapy in 2010. Can J Infect Dis Med Microbiol 2010 0.75
90 Dermatologic manifestations of underlying infectious disease among illicit injection-drug users. J Cutan Med Surg 2008 0.75